Chatbot could put blood pressure control in Patients' hands

NCT ID NCT06845007

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study is testing a chatbot platform called PROMBot that lets people with hypertension report their blood pressure and other health information via text messages. The goal is to see if the chatbot is easy and enjoyable to use, and whether it can help patients stay engaged in their own care. Researchers will interview participants about their experiences and track how often they interact with the chatbot.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A web-based chatbot platform for collecting patient-reported outcomes and providing medication reminders and healthy habit tips
What this could lead to
If successful, this chatbot could offer a simple, engaging way for people with hypertension to track their blood pressure and stay on top of their care, potentially improving follow-up and self-management.
What could go wrong
This is a small, early-stage study focused on user experience, not on health outcomes. The chatbot may not be widely adopted or may not lead to measurable improvements in blood pressure control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CUF

    Lisbon, Lisbon District, 1000, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.